Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Executive summary of the Stages of Reproductive Aging Workshop + 10
1.623
Zitationen
9
Autoren
2012
Jahr
Abstract
OBJECTIVE: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period. METHODS: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimüllerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus. RESULTS: STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics. CONCLUSIONS: STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.
Ähnliche Arbeiten
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 · 15.774 Zit.
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 · 6.255 Zit.
Osteoporosis Prevention, Diagnosis, and Therapy
2001 · 5.473 Zit.
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
2004 · 4.455 Zit.
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 · 3.368 Zit.
Autoren
Institutionen
- University of Michigan(US)
- Ann Arbor Center for Independent Living(US)
- North American Menopause Society(US)
- Harvard University(US)
- Endocrine Society(US)
- New York Proton Center(US)
- Columbia University(US)
- University of Illinois Chicago(US)
- St. Vincent's Birmingham(US)
- American Society for Reproductive Medicine(US)
- National Institute on Aging(US)
- Institute of Aging(CA)